Related Experiment Video

Updated: Jun 17, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

[Epidemiology of hepatitis C virus in Peru and Latin America]

Milagros Dávalos Moscol1

  • 1Médico Jefe Unidad de Hígado, Hospital Naccional Edgardo Rebagliati Martins, EsSalud.

Revista De Gastroenterologia Del Peru : Organo Oficial De La Sociedad De Gastroenterologia Del Peru
|January 13, 2010
PubMed

Insights

Hepatitis C virus (HCV) infection is a global health issue, with prevalence in Latin America around 1-2%. Further epidemiological studies are crucial for effective health strategies against HCV in Peru.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Epidemiology

Context:

  • Hepatitis C virus (HCV) poses a significant global health challenge, contributing to chronic hepatitis, cirrhosis, and liver cancer.
  • In the USA and Europe, HCV is a leading cause of liver transplantation.
  • Latin America reports an HCV seroprevalence of 1-2%, with specific risk groups identified.

Purpose:

  • To summarize the epidemiological landscape of Hepatitis C virus (HCV) in Latin America, with a specific focus on Peru.
  • To highlight prevalent HCV genotypes and identify at-risk populations.
  • To underscore the need for expanded epidemiological research to inform public health interventions.

Summary:

  • Hepatitis C virus (HCV) infection is a global health concern, with Latin America showing a 1-2% seroprevalence, predominantly genotype 1.
  • In Peru, HCV prevalence is approximately 1%, concentrated in the jungle region, with identified risk factors including transfusions, hemodialysis, and healthcare workers.
  • Urgent need for more epidemiological studies in Peru to understand the full scope of HCV infection and guide health strategies.

Impact:

  • Informing public health policy and resource allocation for Hepatitis C virus (HCV) prevention and treatment programs in Latin America.
  • Guiding targeted screening and intervention efforts towards identified high-risk populations.
  • Contributing to a better understanding of the disease burden and facilitating the development of more effective national health strategies.

More Related Videos

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...